CUE1/CUE1+
Parkinson's Disease Symptom Management (e.g., slowness, stiffness, freezing of gait)
CommercialActive
Key Facts
Indication
Parkinson's Disease Symptom Management (e.g., slowness, stiffness, freezing of gait)
Phase
Commercial
Status
Active
Company
About Charco Neurotech
Charco Neurotech is a private, commercial-stage medical device company founded in 2019 in London. It has developed and launched the CUE1/CUE1+, a wearable device that uses pulsed cueing and high-frequency focused vibrotactile stimulation to manage Parkinson's disease symptoms. With over 3,000 users, pilot data suggests clinically significant improvements in motor scores. The company operates on a direct-to-consumer/medical device sales model and is supported by design, engineering, and clinical expertise.
View full company profile